Related Experiment Video

Updated: Aug 30, 2026

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

A signaling mechanism for growth-related expression of fetal hemoglobin

Natarajan V Bhanu1, Tiffany A Trice, Y Terry Lee

  • 1Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Blood
|November 1, 2003
PubMed

Insights

Inhibition of MEK1/2 signaling with PD98059 significantly increases fetal hemoglobin levels in erythroid progenitor cells. This finding offers potential new strategies for treating beta hemoglobinopathies.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Elevated fetal hemoglobin (HbF) is observed in conditions of stressed or malignant erythropoiesis.
  • Understanding the regulation of HbF expression is crucial for developing therapies for hemoglobinopathies.

Purpose of the Study:

  • To investigate the role of growth-related signaling pathways in fetal hemoglobin expression.
  • To identify specific molecular targets for modulating HbF levels.

Main Methods:

  • Human erythroid progenitor cells were cultured with erythropoietin (EPO) and stem cell factor (SCF).
  • The effect of the MEK1/2 inhibitor PD98059 on HbF levels was assessed.
  • Western blot and quantitative PCR were used to analyze protein phosphorylation and globin mRNA expression.

Main Results:

  • PD98059 treatment significantly increased fetal hemoglobin levels, showing a dose-dependent response.
  • In the presence of SCF, PD98059 inhibited MEK and p44MAPK phosphorylation.
  • SCF was necessary for MEK and p44MAPK phosphorylation, and gamma-globin mRNA levels increased.

Conclusions:

  • MEK1/2 signaling is a key regulator of fetal hemoglobin production in erythroid progenitor cells.
  • Targeting specific growth-related pathways, like MEK1/2, may provide novel therapeutic approaches for beta hemoglobinopathies.

More Related Videos

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...